References
- MansourAMShieldsJAAnnesleyWHJrMacular degeneration in angioid streaksOphthalmologica198819736412460816
- ClarksonJGAltmanRDAngioid streaksSurv Ophthalmol1982262352467046115
- SingermanLJHatemGLaser treatment of choroidal neovascular membranes in angioid streaksRetina1981175836184760
- PeceAAvanzaPGalliLBrancatoRLaser photocoagulation of choroidal neovascularization in angioid streaksRetina19971712169051836
- MenchiniUVirgiliGIntroiniUOutcome of choroidal neovascularization in angioid streaks after photodynamic therapyRetina20042476377115492632
- ZarbinMarcoShould corticosteroids be considered as part of the standard care with photodynamic therapy?Am J Ophthalmol2006124563571
- SpaideRSorensonJMarananLCombined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology20031101517152512917166
- RicciFCedroneCCerulliLStandardized measurement of visual acuityOphthalmic Epidemiol1998541539575537
- CiullaTACriswellMHDanisRPHillTEIntravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat modelArch Ophthalmol200111939940411231773
- GilliesMCSimpsonJMLuoWA randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year resultsArch Ophthalmol200312166767312742844
- SpaideRFSorensonJMarananLPhotodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularizationOphthalmology200511230130415691567
- AriasLGarcia-ArumiJRamonJMPhotodynamic Therapy with Intravitreal Triamcinolone in Predominantly Classic Choroidal Neovascularization. One-Year Results of a RandomizedStudy Ophthalmology200611212271231
- KaiserPKVerteporfin. therapy in combination with triamcinolone: published studies investigating a potential synergistic effectCurr Med Res Opin20052170571315969870
- SandowskiTSteinmeyerJEffects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytesBiochem Pharmacol20026421722712123742
- WangYSFriedrichsUEiclerWInhibitory effects of triamcinolone acetonide on bFGF- induced migration and tube formation in choroidal microvascular endothelial cellsGraefes Arch Clin Exp Ophthalmol2002240424811954780
- GordonSGOverlandJFFoleyJEvidence for increased protease activity secreted from cultured fibroblasts from patients with pseudoxanthoma elasticumConn Tissue Res197866168
- SchwartzECruickshankFALebwohlMGElastase-like protease and elastolytic activities expressed in cultured dermal fibroblasts derived from lesional skin of patients with pseudoxanthoma elasticum, actinic elastosis, and cutis laxaClin Chim Acta19881762192243180471
- QuaglinoDSartorLGarbisaSDermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potentialBiochim Biophys Acta20051741424715955448
- AhmadiehHTaeiRSoheilianMRiazi-EsfahaniMAhadiHSingle-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degenerationEur J Ophthalmol20081829730018320527
- TeixeiraAMoraesNFarahMEBonomoPPChoroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaksActa Ophthalmol Scand20068483583617083556
- RinaldiMdell’OmoRRomanoMIntravitreal bevacizumab (Avastin) in choroidal neovascularization secondary to angioid streaksArch Ophthalmol20071251422142317923555
- NishantSKavithaVVishaliGRamandeepSAmodGIntravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaksIndian J Ophthalmol20075545745817951904
- LommatzchASpitalGTrieschmannMPauleikhoffDIntraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaksOphthalmologe200710432532817334745
- BhatnagarPFreudBKSpaideRFIntravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticumRetina20072789790217891014